FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116730178> ?p ?o ?g. }

• W2116730178 endingPage "1583" @default.
• W2116730178 startingPage "1578" @default.
• W2116730178 abstract "Some retrospective studies have suggested a beneficial influence of angiotensin-converting enzyme (ACE) inhibitors on the progression of IgA nephropathy (IgAN), but prospective and controlled studies demonstrating this effect are lacking. Forty-four patients with biopsy-proven IgAN, proteinuria > or = 0.5 g/d, and serum creatinine (SCr) < or = 1.5 mg/dl were randomly assigned either to receive enalapril (n = 23) or to a control group (n = 21) in whom BP was controlled with antihypertensives other than ACE inhibitors. Primary outcome was renal survival estimated by a 50% increase in baseline SCr. Secondary outcomes were the presence of a SCr > 1.5 mg/dl at the last visit and the evolution of proteinuria. Baseline clinical findings were similar at baseline between enalapril-treated and control group, and there were no differences in BP control during follow-up. Mean follow-up was 78 +/- 37 mo in the enalapril group and 74 +/- 36 mo in the control group. Three patients (13%) in the enalapril group and 12 (57%) in the control group reached the primary end point (P < 0.05). Kaplan-Meier renal survival was significantly better in enalapril group than in control group: 100% versus 70% after 4 yr and 92% versus 55% after 7 yr (P < 0.05). Three patients in the enalapril group (13%) and 11 (52%) in the control group showed SCr > 1.5 mg/dl at the last visit (P < 0.05). Proteinuria significantly decreased in the enalapril group, whereas it tended to increase in the control group (P < 0.001 between groups). In conclusion, ACE inhibitors significantly improve renal survival in proteinuric IgAN with normal or moderately reduced renal function." @default.
• W2116730178 created "2016-06-24" @default.
• W2116730178 creator A5025852019 @default.
• W2116730178 creator A5036894659 @default.
• W2116730178 creator A5049224814 @default.
• W2116730178 creator A5052017202 @default.
• W2116730178 creator A5053728193 @default.
• W2116730178 date "2003-06-01" @default.
• W2116730178 modified "2023-09-30" @default.
• W2116730178 title "Treatment of IgA Nephropathy with ACE Inhibitors" @default.
• W2116730178 cites W1979072447 @default.
• W2116730178 cites W1981894444 @default.
• W2116730178 cites W1989492092 @default.
• W2116730178 cites W1998434576 @default.
• W2116730178 cites W2008478236 @default.
• W2116730178 cites W2027524654 @default.
• W2116730178 cites W2031410978 @default.
• W2116730178 cites W2033180759 @default.
• W2116730178 cites W2034580483 @default.
• W2116730178 cites W2067744739 @default.
• W2116730178 cites W2072791179 @default.
• W2116730178 cites W2074850565 @default.
• W2116730178 cites W2075391935 @default.
• W2116730178 cites W2082105506 @default.
• W2116730178 cites W2089876742 @default.
• W2116730178 cites W2105803357 @default.
• W2116730178 cites W2139030893 @default.
• W2116730178 cites W2170453602 @default.
• W2116730178 cites W2312400976 @default.
• W2116730178 cites W2318993770 @default.
• W2116730178 cites W2321910386 @default.
• W2116730178 cites W2615684303 @default.
• W2116730178 cites W3156148333 @default.
• W2116730178 cites W4241655994 @default.
• W2116730178 cites W4255843096 @default.
• W2116730178 doi "https://doi.org/10.1097/01.asn.0000068460.37369.dc" @default.
• W2116730178 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12761258" @default.
• W2116730178 hasPublicationYear "2003" @default.
• W2116730178 type Work @default.
• W2116730178 sameAs 2116730178 @default.
• W2116730178 citedByCount "301" @default.
• W2116730178 countsByYear W21167301782012 @default.
• W2116730178 countsByYear W21167301782013 @default.
• W2116730178 countsByYear W21167301782014 @default.
• W2116730178 countsByYear W21167301782015 @default.
• W2116730178 countsByYear W21167301782016 @default.
• W2116730178 countsByYear W21167301782017 @default.
• W2116730178 countsByYear W21167301782018 @default.
• W2116730178 countsByYear W21167301782019 @default.
• W2116730178 countsByYear W21167301782020 @default.
• W2116730178 countsByYear W21167301782021 @default.
• W2116730178 countsByYear W21167301782022 @default.
• W2116730178 countsByYear W21167301782023 @default.
• W2116730178 crossrefType "journal-article" @default.
• W2116730178 hasAuthorship W2116730178A5025852019 @default.
• W2116730178 hasAuthorship W2116730178A5036894659 @default.
• W2116730178 hasAuthorship W2116730178A5049224814 @default.
• W2116730178 hasAuthorship W2116730178A5052017202 @default.
• W2116730178 hasAuthorship W2116730178A5053728193 @default.
• W2116730178 hasBestOaLocation W21167301781 @default.
• W2116730178 hasConcept C126322002 @default.
• W2116730178 hasConcept C126894567 @default.
• W2116730178 hasConcept C134018914 @default.
• W2116730178 hasConcept C159641895 @default.
• W2116730178 hasConcept C27016395 @default.
• W2116730178 hasConcept C2775940317 @default.
• W2116730178 hasConcept C2779561371 @default.
• W2116730178 hasConcept C2779611605 @default.
• W2116730178 hasConcept C2780091579 @default.
• W2116730178 hasConcept C2780306776 @default.
• W2116730178 hasConcept C2781184683 @default.
• W2116730178 hasConcept C555293320 @default.
• W2116730178 hasConcept C71924100 @default.
• W2116730178 hasConcept C84393581 @default.
• W2116730178 hasConcept C90924648 @default.
• W2116730178 hasConceptScore W2116730178C126322002 @default.
• W2116730178 hasConceptScore W2116730178C126894567 @default.
• W2116730178 hasConceptScore W2116730178C134018914 @default.
• W2116730178 hasConceptScore W2116730178C159641895 @default.
• W2116730178 hasConceptScore W2116730178C27016395 @default.
• W2116730178 hasConceptScore W2116730178C2775940317 @default.
• W2116730178 hasConceptScore W2116730178C2779561371 @default.
• W2116730178 hasConceptScore W2116730178C2779611605 @default.
• W2116730178 hasConceptScore W2116730178C2780091579 @default.
• W2116730178 hasConceptScore W2116730178C2780306776 @default.
• W2116730178 hasConceptScore W2116730178C2781184683 @default.
• W2116730178 hasConceptScore W2116730178C555293320 @default.
• W2116730178 hasConceptScore W2116730178C71924100 @default.
• W2116730178 hasConceptScore W2116730178C84393581 @default.
• W2116730178 hasConceptScore W2116730178C90924648 @default.
• W2116730178 hasIssue "6" @default.
• W2116730178 hasLocation W21167301781 @default.
• W2116730178 hasLocation W21167301782 @default.
• W2116730178 hasOpenAccess W2116730178 @default.
• W2116730178 hasPrimaryLocation W21167301781 @default.
• W2116730178 hasRelatedWork W1981894444 @default.
• W2116730178 hasRelatedWork W2008644969 @default.
• W2116730178 hasRelatedWork W2129198067 @default.

• next